Corynebacterium CDC group A-4 native valve endocarditis.
A patient with endocarditis caused by Corynebacterium CDC Group A-4 is described. This is the first case in the literature of endocarditis caused by this bacteria, and is unique in that the patient was immune competent and the infection occurred on a native valve. This case illustrates that corynebacteria cannot be considered a contaminant and that the exact pathogen should be identified.
Lifshitz
A
A
Department of Internal Medicine D, Beilinson Medical Center, Sackler School of Medicine, Petah Tiqva, Israel.
Arber
N
N
Pras
E
E
Samra
Z
Z
Pinkhas
J
J
Sidi
Y
Y
D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D003352:Corynebacterium / Q000302:isolation & purification*; D003354:Corynebacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D004334:Drug Administration Schedule; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005839:Gentamicins / Q000627:therapeutic use; D006351:Heart Valves / Q000382:microbiology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male
D005839:Gentamicins; D000667:Ampicillin